Skip to content
All Sections
Subscribe Now
63°F
Sunday, September 21st 2025
Today's E-Edition
Home Page
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
Branded Content
Paid Content by Brandpoint
SUBSCRIBE NOW
Sign up for email newsletters
Sign Up
Subscribe
Account Settings
Contact Us
Log Out
Spoof a user
Sign up for email newsletters
Sign Up
Subscribe
Search
Silicon Valley
63°F
Sunday, September 21st 2025
Today's E-Edition
Business
Technology
Commercial Real Estate
Housing
Marketplace
The Mercury News
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Silicon Valley 150
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Biogen Inc
Recent news which mentions Biogen Inc
< Previous
1
2
3
4
Next >
Stocks making the biggest moves midday: Spotify, RTX, General Electric and more
July 25, 2023
Tags
MSCI Inc
General Electric Co
United Parcel Service Inc
From
CNBC.com News
Biogen to cut 1,000 jobs to save costs as company prepares for Leqembi launch
July 25, 2023
Tags
Biotech and Pharmaceuticals
Biotechnology
Business
From
CNBC.com News
5 things to know before the stock market opens Tuesday
July 18, 2023
Tags
Tesla Inc
Bank of America Corp
Business News
From
CNBC.com News
Eli Lilly expects FDA decision on Alzheimer's treatment donanemab by the end of the year
July 17, 2023
Tags
Pharmaceuticals
US: News
Biogen Inc
From
CNBC.com News
Medicare will pay for Alzheimer's drug Leqembi. What patients and doctors should know
July 08, 2023
Tags
Social issues
Biotech and Pharmaceuticals
U/S/ Economy
From
CNBC.com News
Sales of Alzheimer’s drug Leqembi may be slow initially but could pick up in 2024
July 07, 2023
Tags
Alzheimer's disease
Law and Regulation
Business News
From
CNBC.com News
Stocks making the biggest moves midday: Rivian, Levi Strauss, Biogen, First Solar and more
July 07, 2023
Tags
Economy
Eisai Co Ltd
TG Therapeutics Inc
From
CNBC.com News
Stocks making the biggest premarket moves: Levi Strauss, Biogen, Alibaba and more
July 07, 2023
Tags
Alibaba Group Holding Ltd
Business
Tesla Inc
From
CNBC.com News
Japanese pharma Eisai slides 4% despite FDA approval for Alzheimer's drug
July 07, 2023
Tags
World Markets
Biogen Inc
Pharmaceuticals
From
CNBC.com News
FDA approves Alzheimer’s drug Leqembi, paving way for broader Medicare coverage
July 06, 2023
Tags
World News
Health care industry
Health & Science
From
CNBC.com News
Stocks making the biggest moves midday: JD.Com, Biogen, Oracle and more
June 13, 2023
Tags
Market Insider
Carnival Corp
Morgan Stanley
From
CNBC.com News
FDA advisors to weigh whether Alzheimer's drug Leqembi should receive full approval
June 09, 2023
Tags
U/S/ Economy
Social issues
Biotech and Pharmaceuticals
From
CNBC.com News
Bernie Sanders says price of Alzheimer's treatment is unconscionable, calls on HHS to take action
June 07, 2023
Tags
Health care industry
US Economy
Health & Science
From
CNBC.com News
Jim Cramer expects defensive stocks to be resilient as debt ceiling talks drag on
May 15, 2023
Tags
U/S/ Markets
Mad Money
Ross Stores Inc
From
CNBC.com News
Alzheimer's treatment Leqembi could cost Medicare up to $5 billion per year, study estimates
May 12, 2023
Tags
Eli Lilly and Co
Biogen Inc
US: News
From
CNBC.com News
Stocks making the biggest moves premarket: Starbucks, AMD, Pearson, PacWest & more
May 03, 2023
Tags
Finance
Biogen Inc
Advanced Micro Devices Inc
From
CNBC.com News
Bipartisan attorneys general call on Medicare to cover Alzheimer's treatments
May 01, 2023
Tags
US Economy
Health care industry
Eisai Co Ltd
From
CNBC.com News
Alzheimer’s patients may wait years to get treated with new drugs, putting them at risk of more severe disease
April 30, 2023
Tags
Disease outbreaks
Eisai Co Ltd
Health care industry
From
CNBC.com News
Alzheimer's: Medicare will cover Leqembi for all patients if FDA approves drug, CMS chief says
April 26, 2023
Tags
Biotech and Pharmaceuticals
Social issues
U/S/ Economy
From
CNBC.com News
Biogen isn't concerned about competing with Eli Lilly in the Alzheimer’s drug space, CEO says
April 25, 2023
Tags
Breaking News: Business
Science
Biotechnology
From
CNBC.com News
FDA grants accelerated approval for Biogen ALS drug that treats rare form of the disease
April 25, 2023
Tags
Health care industry
Health & Science
Companies
From
CNBC.com News
Alzheimer’s patients retain the benefits of Leqembi even when they stop the drug, Eisai says
April 06, 2023
Tags
Biotechnology
Breaking News: Business
Science
From
CNBC.com News
Eli Lilly says experimental Alzheimer's drug reduces brain plaque in early study
April 05, 2023
Tags
Breaking News: Business
Science
Biotechnology
From
CNBC.com News
FDA advisors reject Biogen's ALS drug for rare and aggressive form of the disease
March 22, 2023
Tags
Biotech and Pharmaceuticals
Breaking news
US: News
From
CNBC.com News
FDA staff says Biogen's ALS drug may have a 'clinical benefit' on a rare form of the disease
March 20, 2023
Tags
Health & Science
Companies
Health care industry
From
CNBC.com News
Veterans' Health will cover Alzheimer's treatment Leqembi for some patients
March 13, 2023
Tags
Eisai Co Ltd
Health & Science
US Economy
From
CNBC.com News
FDA will review Eisai's and Biogen's Alzheimer's treatment Leqembi with decision on full approval expected in early July
March 06, 2023
Tags
U/S/ Economy
Biotech and Pharmaceuticals
Epidemics
From
CNBC.com News
Medicare rejects Alzheimer's Association request for unrestricted coverage of treatments like Leqembi
February 23, 2023
Tags
Disease outbreaks
World News
Coronavirus
From
CNBC.com News
Stocks making the biggest moves midday: Deere, Airbnb, AutoNation, Moderna and more
February 17, 2023
Tags
Breaking News: Markets
Bio Rad Laboratories Inc
Stock markets
From
CNBC.com News
Senators call on Medicare to offer broad coverage of Alzheimer's treatments as public pressure grows
February 17, 2023
Tags
US: News
Biogen Inc
Coronavirus
From
CNBC.com News
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.
Close